Arrhythmias & electrophysiology

Stellate ganglion instrumentation for pharmacological blockade, nerve recording, and stimulation in patients with ventricular arrhythmias: Preliminary experience

Heart RhythmPublished Observational case series

Authors' conclusion

SGB provides short-term VA control, but has no benefit in the absence of definitive VA therapies. SG recording and stimulation is feasible and may have value to elicit VA and understand neural mechanisms of VA in the electrophysiology laboratory.

Study context

Population
Patients with ventricular arrhythmias
Participants
25 vs 11
Exposure
Group 1 vs Group 2
  • Group 1n = 25
  • Group 2n = 11
Outcome
Outcomes of SGB and feasibility of SG stimulation and recording

Main finding

As reported in the abstract

Group 1: free of VA up to 72 hours postprocedure

19

76.0%

Group 1: VA recurrence

15

60.0%

Group 1: time to VA recurrence, mean ± SD (days)

5.47 ± 4.52

Group 2: unequivocal signals temporally associated with arrhythmias

4 of 11

Observational data: associations, not effects.

Original publication

Stellate ganglion instrumentation for pharmacological blockade, nerve recording, and stimulation in patients with ventricular arrhythmias: Preliminary experience. Heart Rhythm. Published 28 February 2023. doi:10.1016/j.hrthm.2023.02.024

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.